These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 15660501)

  • 1. Metabolic syndrome: a clinical and molecular perspective.
    Moller DE; Kaufman KD
    Annu Rev Med; 2005; 56():45-62. PubMed ID: 15660501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management issues in the metabolic syndrome.
    Deedwania PC; Gupta R
    J Assoc Physicians India; 2006 Oct; 54():797-810. PubMed ID: 17214277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of metabolic syndrome.
    Wagh A; Stone NJ
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):213-28. PubMed ID: 15151470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
    Tjokroprawiro A
    Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges associated with metabolic syndrome.
    Spinler SA
    Pharmacotherapy; 2006 Dec; 26(12 Pt 2):209S-217S. PubMed ID: 17125447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of metabolic profile in a clinical setting.
    Pervanidou P; Kanaka-Gantenbein C; Chrousos GP
    Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):589-95. PubMed ID: 16912555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of atherogenic dyslipidemia of the metabolic syndrome: evolving rationale for combined drug therapy.
    Vega GL
    Endocrinol Metab Clin North Am; 2004 Sep; 33(3):525-44, vi. PubMed ID: 15262295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging aspects of pharmacotherapy for obesity and metabolic syndrome.
    Nisoli E; Carruba MO
    Pharmacol Res; 2004 Nov; 50(5):453-69. PubMed ID: 15458765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of diagnosing and treating the metabolic syndrome in reducing cardiovascular risk.
    Smith SR
    Obesity (Silver Spring); 2006 Jun; 14 Suppl 3():128S-134S. PubMed ID: 16931494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of serum adiponectin level as a diagnostic marker of metabolic syndrome in obese Japanese children.
    Ogawa Y; Kikuchi T; Nagasaki K; Hiura M; Tanaka Y; Uchiyama M
    Hypertens Res; 2005 Jan; 28(1):51-7. PubMed ID: 15969255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome.
    Vitale C; Marazzi G; Volterrani M; Aloisio A; Rosano G; Fini M
    Minerva Med; 2006 Jun; 97(3):219-29. PubMed ID: 16855517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective role of pravastatin in the pathogenesis of the metabolic syndrome.
    Yamagishi S; Matsui T; Sato T; Takeuchi M
    Med Hypotheses; 2006; 66(3):609-11. PubMed ID: 16171951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The progression of cardiovascular risk to cardiovascular disease.
    Rosin BL
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S3-8. PubMed ID: 17934392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic syndrome as an endocrine disease: is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis?
    Schindler C
    Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):7-26. PubMed ID: 19124392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome: an evolving concept.
    Cortez-Dias N; Martins S; Fiuza M
    Rev Port Cardiol; 2007 Dec; 26(12):1409-21. PubMed ID: 18338669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis.
    Reilly MP; Wolfe ML; Rhodes T; Girman C; Mehta N; Rader DJ
    Circulation; 2004 Aug; 110(7):803-9. PubMed ID: 15289378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic syndrome: metabolic changes with vascular consequences.
    Wassink AM; Olijhoek JK; Visseren FL
    Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome.
    Lin JD; Chiou WK; Weng HF; Fang JT; Liu TH
    Clin Nutr; 2004 Dec; 23(6):1313-23. PubMed ID: 15556253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic syndrome - an ongoing story.
    Duvnjak L; Duvnjak M
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():19-24. PubMed ID: 20388942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.